Burden of non-communicable diseases in Iran: past, present, and future.

Journal of Diabetes & Metabolic Disorders Pub Date : 2020-10-27 eCollection Date: 2024-12-01 DOI:10.1007/s40200-020-00669-z
Arya Aminorroaya, Nima Fattahi, Sina Azadnajafabad, Esmaeil Mohammadi, Kosar Jamshidi, Mahtab Rouhifard Khalilabad, Sahar Mohammadi Fateh, Shohreh Naderimagham, Negar Rezaei, Bagher Larijani, Farshad Farzadfar
{"title":"Burden of non-communicable diseases in Iran: past, present, and future.","authors":"Arya Aminorroaya, Nima Fattahi, Sina Azadnajafabad, Esmaeil Mohammadi, Kosar Jamshidi, Mahtab Rouhifard Khalilabad, Sahar Mohammadi Fateh, Shohreh Naderimagham, Negar Rezaei, Bagher Larijani, Farshad Farzadfar","doi":"10.1007/s40200-020-00669-z","DOIUrl":null,"url":null,"abstract":"<p><p>Iran, as an in-transition country, tackled communicable diseases and now is confronting emerging challenges of non-communicable diseases (NCDs) in the path to reach health for everyone at all ages by 2030. Across Iran, death-averting treatments of NCDs have been expanded recently which might cause a shift toward a greater share of years lived with disability (YLDs) compared to years of life lost (YLLs) in the disability-adjusted life years of NCDs. Since the management of disability differs from the reduction of mortality in terms of public health policies, depicting the current picture of the burden of NCDs is principal for policymakers in achieving health for all. In this communication, we briefly reviewed our current knowledge about the burden of NCDs in Iran and found that burdens of cardiovascular diseases and asthma are shifting toward greater YLDs than YLLs. In addition to expanding preventive measures and maintenance of the current system, this profile calls policymakers for the development of more rehabilitation centers for patients with ischemic heart disease, stroke, and respiratory diseases to mitigate their disabilities. The consistent increase in the age-standardized YLD rate of neoplasms necessitates providing rehabilitation centers as well. Morbidity and mortality of diabetes have increased robustly which warrant extensive preventive and control measures. It should be noted that the estimates of the Global Burden of Disease study offer us invaluable insights on the burden of diseases in Iran; nonetheless, efforts for gathering nationally-representative data, e.g., National and Subnational Burden of Diseases, Injuries, and Risk Factors study, are strongly encouraged in the future.</p>","PeriodicalId":15604,"journal":{"name":"Journal of Diabetes & Metabolic Disorders","volume":"70 1","pages":"1793-1799"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11599516/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Diabetes & Metabolic Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40200-020-00669-z","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Iran, as an in-transition country, tackled communicable diseases and now is confronting emerging challenges of non-communicable diseases (NCDs) in the path to reach health for everyone at all ages by 2030. Across Iran, death-averting treatments of NCDs have been expanded recently which might cause a shift toward a greater share of years lived with disability (YLDs) compared to years of life lost (YLLs) in the disability-adjusted life years of NCDs. Since the management of disability differs from the reduction of mortality in terms of public health policies, depicting the current picture of the burden of NCDs is principal for policymakers in achieving health for all. In this communication, we briefly reviewed our current knowledge about the burden of NCDs in Iran and found that burdens of cardiovascular diseases and asthma are shifting toward greater YLDs than YLLs. In addition to expanding preventive measures and maintenance of the current system, this profile calls policymakers for the development of more rehabilitation centers for patients with ischemic heart disease, stroke, and respiratory diseases to mitigate their disabilities. The consistent increase in the age-standardized YLD rate of neoplasms necessitates providing rehabilitation centers as well. Morbidity and mortality of diabetes have increased robustly which warrant extensive preventive and control measures. It should be noted that the estimates of the Global Burden of Disease study offer us invaluable insights on the burden of diseases in Iran; nonetheless, efforts for gathering nationally-representative data, e.g., National and Subnational Burden of Diseases, Injuries, and Risk Factors study, are strongly encouraged in the future.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
伊朗的非传染性疾病负担:过去、现在和未来。
作为一个转型国家,伊朗解决了传染病问题,现在在到2030年实现所有年龄段人人享有健康的道路上,面临着非传染性疾病的新挑战。在伊朗各地,最近已经扩大了对非传染性疾病的预防死亡治疗,这可能导致在非传染性疾病的残疾调整生命年中,残疾生活年数(YLDs)的比例比丧失生命年数(YLLs)的比例更高。由于在公共卫生政策方面,残疾管理不同于降低死亡率,因此,决策者在实现人人享有健康的过程中,首先要了解非传染性疾病负担的现状。在这篇通讯中,我们简要回顾了我们目前对伊朗非传染性疾病负担的了解,发现心血管疾病和哮喘的负担正在转向更大的YLDs而不是YLLs。除了扩大预防措施和维持现有系统外,该概况还呼吁决策者为缺血性心脏病、中风和呼吸系统疾病患者建立更多的康复中心,以减轻他们的残疾。肿瘤年龄标准化YLD率的持续增长也需要提供康复中心。糖尿病的发病率和死亡率急剧上升,需要采取广泛的预防和控制措施。应当指出,全球疾病负担研究的估计数为我们提供了关于伊朗疾病负担的宝贵见解;尽管如此,强烈鼓励今后努力收集具有全国代表性的数据,例如国家和国家以下各级疾病、伤害和风险因素负担研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Insights from the potential impact of pasteurized Akkermansia muciniphila in zebrafish models of obesity and diabetes Association of common single-nucleotide polymorphism of HHEX with type 2 diabetes mellitus Association of CIITA (rs8048002) and CLEC2D (rs2114870) gene variants and type 1 diabetes mellitus Small interfering RNA (siRNA) as a potential gene silencing strategy for diabetes and associated complications: challenges and future perspectives The global prevalence of sexual dysfunction in men with thyroid gland disorders: a systematic review and meta-analysis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1